| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2012 | 2012 Guidelines of the Taiwan Society of Cardiology (TSOC) for the management of ST-segment elevation myocardial infarction | Li Y.-H.; Yeh H.-I.; CHIA-TI TSAI ; Liu P.-Y.; Lin T.-H.; Wu T.-C.; Hung K.-C.; Hsieh Y.-C.; Mar G.-Y.; Fang C.-Y.; Chiu K.-M.; Cheng J.-J.; Chen J.-H. | Acta Cardiologica Sinica | 31 | | |
| 1988 | Alterations in thyroidal economy in a systemic illness induced by turpentine oil injection to the rat | TIEN-SHANG HUANG ; Chopra I.J.; Boado R.; Wu T.-C.; Tashkin D.P.; Solomon D.H.; Teco G.N.C. | Acta Endocrinologica | 5 | 8 | |
| 2018 | Analyses of the transcriptome of Bombyx mori cells infected with either BmNPV or AcMNPV | Chen Y.-W.; Wu C.-P.; Wu T.-C.; Wu Y.-L.; YUEH-LUNG WU | Journal of Asia-Pacific Entomology | 7 | 7 | |
| 2000 | Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine | Chang E.Y.; CHIEN-HUNG CHEN ; Ji H.; Wang T.-L.; Hung K.; Lee B.P.; Huang A.Y.C.; Kurman R.J.; Pardoll D.M.; Wu T.-C. | International Journal of Cancer | 71 | | |
| 2000 | Antigen-specific immunotherapy for human papillomavirus 16 E7-expressing tumors grown in the liver | CHIEN-HUNG CHEN ; Suh K.W.; Ji H.; Choti M.A.; Pardoll D.M.; Wu T.-C. | Journal of Hepatology | 17 | 12 | |
| 2000 | Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines | CHIEN-HUNG CHEN ; Wang T.-L.; Hung C.-F.; Pardoll D.M.; Wu T.-C. | Vaccine | 86 | 70 | |
| 2001 | Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen | Hung C.-F.; WEN-FANG CHENG ; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C. | Cancer Research | 0 | | |
| 2002 | Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion | WEN-FANG CHENG ; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C. | Human Gene Therapy | 113 | 103 | |
| 2004 | Carvedilol inhibits tumor necrosis factor-α-induced endothelial transcription factor activation, adhesion molecule expression, and adhesiveness to human mononuclear cells | Chen J.-W.; Lin F.-Y.; Chen Y.-H.; Wu T.-C.; YUH-LIEN CHEN ; Lin S.-J. | Arteriosclerosis, Thrombosis, and Vascular Biology | 45 | 40 | |
| 2007 | Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis | Wu T.-C.; Chen Y.-H.; Leu H.-B.; YUH-LIEN CHEN ; Lin F.-Y.; Lin S.-J.; Chen J.-W. | Free Radical Biology and Medicine | 49 | 39 | |
| 2003 | CD8+ T cells, NK cells and IFN-γ are important for control of tumor with downregulated MHC class I expression by DNA vaccination | WEN-FANG CHENG ; Hung C.F.; Lin K.Y.; Ling M.; Juang J.; He L.; Lin C.T.; Wu T.-C. | Gene Therapy | 53 | 48 | |
| 2005 | Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis | WEN-FANG CHENG ; Hung C.-F.; CHI-AN CHEN ; CHIEN-NAN LEE ; Su Y.-N.; Chai C.-Y.; Boyd D.A.K.; CHANG-YAO HSIEH ; Wu T.-C. | Vaccine | 27 | 24 | |
| 2018 | Clinical predictors of liver fibrosis in patients with chronic hepatitis B virus infection from children to adults | JIA-FENG WU ; Song S.-H.; Lee C.-S.; HUEY-LING CHEN ; YEN-HSUAN NI ; HONG-YUAN HSU ; Wu T.-C.; MEI-HWEI CHANG | Journal of Infectious Diseases | 21 | 17 | |
| 2017 | Cloning, expression, and purification of recombinant major mango allergen Man i 1 in Escherichia coli | Tsai W.-C.; Wu T.-C.; BOR-LUEN CHIANG ; Wen H.-W. | Protein Expression and Purification | 24 | 21 | |
| 2016 | Combination with low-dose dextromethorphan improves the effect of amlodipine monotherapy in clinical hypertension a first-in-human, concept-proven, prospective, dose-escalation, multicenter study | Yin W.-H.; Chen P.; Yeh H.-I.; Wang K.-Y.; Hung Y.-J.; Tseng W.-K.; Wen M.-S.; Wu T.-C.; CHAU-CHUNG WU ; Cheng S.-M.; Chen J.-W. | Medicine (United States) | 3 | 2 | |
| 2018 | Comparative leaf proteomic profiling of salt-treated natural variants of Imperata cylindrica | Shih Y.-J.; Chang H.-C.; Tsai M.-C.; Wu T.-Y.; Wu T.-C.; Kao P.; Kao W.-Y.; Chang I.-F.; WEN-YUAN KAO | Taiwania | 0 | 0 | |
| 2018 | Comparative leaf proteomic profiling of salt-treated natural variants of Imperata cylindrica | Shih Y.-J.; Chang H.-C.; Tsai M.-C.; Wu T.-Y.; Wu T.-C.; Kao P.; Kao W.-Y.; WEN-YUAN KAO | Taiwania | 0 | 0 | |
| 2004 | Comparison of HPV DNA vaccines employing intracellular targeting strategies | Kim J.W.; Hung C.-F.; Juang J.; He T.; Kim T.W.; Armstrong D.K.; Pai S.I.; PEI-JER CHEN ; Lin C.-T.; Boyd D.A.; Wu T.-C. | Gene Therapy | 104 | 89 | |
| 2009 | Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: A 20-year follow-up study | MEI-HWEI CHANG ; You S.-L.; Chen C.-J.; CHUN-JEN LIU ; Lee C.-M.; Lin S.-M.; Chu H.-C.; Wu T.-C.; Yang S.-S.; Kuo H.-S.; DING-SHINN CHEN | Journal of the National Cancer Institute | 462 | 397 | |
| 2019 | Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers | KAI-CHI CHANG ; MEI-HWEI CHANG ; CHIEN-NAN LEE ; Chang C.-H.; JIA-FENG WU ; YEN-HSUAN NI ; Wen W.-H.; MING-KWANG SHYU ; Lai M.-W.; Chen S.-M.; Hu J.-J.; Lin H.H.; Hsu J.-J.; Mu S.-C.; Lin Y.-C.; CHUN-JEN LIU ; DING-SHINN CHEN ; Lin L.-H.; HUEY-LING CHEN ; HSIAO-LIN HWA ; Su Y.-N.; JIN-CHUNG SHIH ; KUANG-HAN CHAO ; HONG-YUAN HSU ; YU-CHUN CHIU ; TUNG-HUNG SU ; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Zhao L.-L.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Lee C.-L.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Tsai M.-S.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Lin H.-M.; Peng F.-S.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; The Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study) | Alimentary Pharmacology and Therapeutics | 16 | 17 | |
